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AMINOCYCLOPENTANE CARBOXYLIC 
ACID ( ACPC ) is an unnatural amino acid 
that has been found to possess antitumor ac- 
tivity in animals [12, 81. Following injection 
it appears to be metabolically inert and not to 
interfere with normal tissue respiration. It is 
widely distributed in both cellular fluids and 
tissues but is not incorporated into proteins 
and appears to remain intact within the cell 
[2, 3, 61. For this reason it has been used as 
a model of amino acid transport and has been 
found to be similar in its behavior to L-valine 
and L-leucine [6, 11. 
ACPC which lacks the a-hydrogen of the 
natural metabolizable amino acids may act as 
an amino acid antagonist. This is suggested 
by the observation that the toxicity of ACPC 
in chickens can be alleviated by dietary sup- 
plementation with valine [lo]. ACPC also in- 
hibits the incorporation of valine into rat liver 
[4]. However, Mickelson [ll] failed to ob- 
serve any interference by ACPC with utiliza- 
tion of natural amino acids by certain bac- 
teria. 
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tSecretin and pancreozymin from Boots Pure Drug 
Company, Ltd., Nottingham, England. 
In mice, autoradiographic studies have 
demonstrated a selective concentration of 
ACPC in pancreas and bone marrow [5]. This 
observation suggested the possible use of 
ACPC in the diagnosis and treatment of 
pancreatic disease. Pursuing this thought, 
Sherman et al. [13] studied the tissue distri- 
bution of ACPC in mice, dogs, and rabbits. 
While confirming the selective localization of 
ACPC in the mouse pancreas, they were un- 
able to demonstrate localization in the pan- 
creas of dogs and rabbits. They ascribed the 
observed difference to species differences in 
transport systems and wondered whether 
metabolic pathways in the human would 
more closely resemble those seen in the 
mouse or in the dog. 
Christensen and Clifford [7] noted that the 
urinary excretion of ACPC in humans was 
distinctly different from that seen in rats. It 
therefore seemed appropriate to study the 
tissue distribution of ACPC in primates. 
Experimental Procedures 
Nine Rhesus monkeys weighing between 
3.0 and 4.0 kg. were used. Carboxyl-14C 
ACPC was obtained from the New England 
Nuclear Corporation. The specific activity was 
3.8 mCi./mmole. The ACPC was dissolved in 
200 ml. of sterile lactated Ringers solution at 
a concentration of 1 uCi./ml. 
The monkeys were anesthetized with 
























































































































































































































































































































































































LINDENAUER ET AL.: ACPC IN THE RHESUS MONKEY 
Table 2. Mean Values and Standard Deviations (in parentheses) for the Distribution of ACPC 
Following Intravenous Injection of 2 @/kg. with Secretin Stimulation of 2 units/kg. 
Time Blooda Pancreasb Liver” 
Pancreatic 
J uicen 
15 min. 3510 (536) 10,170 (1840) 11,430 (3863) 
30 min. 2720 (661) 6,730 (2081) 14,350 (4241) 
nUnits for blood and pancreatic juice: counts per min./ml. of whole blood or pancreatic juice. 
bUnits for pancreas and liver: counts per min./gm. wet weight of tissue. 
640 (54) 
146 (46) 
Tab!e 3. Mean Values and Standard Deviations (in parentheses) for the Distribution of ACPC 








9350 ( 813) 








aUnits for blood and pancreatic juice: counts per min./ml. of whole blood or pancreatic juice. 
bUnits for pancreas and liver: counts per min./gm. wet weight of tissue. 
was performed. Two microcurie/kg. of ACPC 
was injected into the inferior vena cava and 
tissue specimens and blood were obtained at 
the appropriate intervals. 
In four monkeys the pancreatic duct was 
cannulated and pancreatic juice was collected 
following stimulation with secretin in two 
monkeys and with pancreozymin in two 
monkeys. The dose of secretin and pancreo- 
zymin was 2 units/kg. given as a single in- 
travenous injection administered simultane- 
ously with the ACPC. 
Blood and tissue specimens were prepared 
for liquid scintillation counting using the 
procedure essentially as described by Chris- 
tensen and Jones [6]. Samples were counted 
in a Packard liquid scintillation spectrometer, 
Model 314X, at settings which gave a 14C- 
efficiency of about 35%. 
RESULTS 
The tissue distribution of ACPC in monkeys 
following intravenous injection is summarized 
in Table 1. There is an initial high concentra- 
tion in the liver which declines to blood levels 
at the end of 24 hours. At early time intervals, 
the concentration of ACPC in the pancreas is 
elevated above blood levels, but does not ap- 
proach the amounts present in the liver. 
Other tissue concentrations are comparable 
to blood levels. ACPC is uniformly present 
in all tissues studied at 24 hours. Following 
stimulation with secretin and pancreozymin 
(Tables 2 and 3) there appears to be no 
significant difference in the concentration of 
ACPC in the pancreas or liver compared to 
controls. There is no significant excretion in 
pancreatic juice. 
DISCUSSION 
The distribution of ACPC in Rhesus mon- 
keys appears to be different from that ob- 
served in mice, rabbits, and dogs as reported 
by Berlinquet et al. [5] and Sherman et al. 
[ 131. In monkeys there appears to be a sig- 
nificant concentration in the liver with some- 
what less present in the pancreas and almost 
none in pancreatic juice. High concentrations 
of ACPC in mouse liver were noted by 
Christensen and Jones [6]. They observed 
ACPC concentrations in the liver that were 
4.5 times as great as in plasma at 6 hours in 
the mouse, whereas concentrations in muscle 
were essentially the same as in plasma. Our 
results with monkeys are similar. 
The high concentration in liver decreases 
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in time, and at 24 hours there is no selective 
concentration by any organ. The failure of 
others to observe high concentrations of 
ACPC in liver may have resulted from their 
not obtaining samples at time intervals less 
than l-2 hours. 
4. 
Large doses of ACPC (375 mg./kg. ) cause 
significant atrophy of the pancreas in the rat 
with loss in pancreas weight of up to 37%. 
There is a decrease in the size of the acini, 
disappearance of zymogen granules, and a 
loss of enzyme activity. However, islets are 
preserved as is glucose tolerance [9]. Further 






Laferte, R. 0. Biochemical studies of an un- 
natural and antitumor amino acid: l-amino- 
cyclopentanecarboxylic acid, II effects on celhr- 
lar respiration and amino acid metabolism. 
Canad. J. Biochem. 40:433, 1962. 
Berlinquet, L., Begin, N., and Sarkar, N. K. 
Mechanism of antitumor action of l-amino-cy- 
clopentane carboxylic acid. Nature ( London), 
194: 1082, 1962. 
Berlinquet, L., Begin, N., and Babineau, L. M. 
Autoradiographic studies of the distribution of 
1-aminocyclopentane carboxyhc acid in normal 
and cancerous mice. Canad. J. Physiol. Phurma- 
coI. 40:1111, 1962. 
Christensen, H. N., and Jones, J. C. Amino 
acid transport models: renal resorption and re- 
sistance to metabolic attack. J. Biol. Chem. 237: 
1203, 1962. 
Christensen, H. N., and Clifford, J. A. Excre- 
tion of 1-aminocyclopentanecarboxylic acid in 
man and the rat. Biochim. Biophys. Acta 62: 
160, 1962. 
8. 
The distribution of ACPC in Rhesus mon- 
keys appears to be different from that ob- 
served in other species. High concentrations 
are noted in the liver following intravenous 
injection. ACPC is concentrated in the pan- 
creas to a lesser degree. There is no significant 
excretion in pancreatic juice. Pancreatic 
stimulation causes no significant change in 
the distribution of ACPC. 
Connors, T. A., Elson, L. A., Haddow, A., and 
Ross, W. C. J. The pharmacology and tumor 
growth inhibitory activity of l-aminocyclopen- 
tane-1-carboxylic acid and related compounds. 
Biochem. Pharmacol. 5: 108, 1960. 
Dunningan, J., Gagnon, P. M., and Berhnquet, 
L. Selective effect of l-amino cyclopentane car- 
boxylic acid on pancreatic acinor tissue and its 
protease activity. Biochem. Pharmucol. 13:517, 
1964. 
REFERENCES 
1. Akedo, H., and Christensen, H. N. Transfer of 
amino acids across the intestine: a new model 
amino acid. J. Biol. Chem. 237:113, 1962. 
2. Berlinquet, L., Begin, N., Babineau, L. M., Mar- 
tel, F., Vallee, R., and Laferte, It. 0. Biochemi- 
cal studies of an unnatural and antitumor amino 
acid: 1-aminocyclopentanecarboxylic acid, 1. tox- 







3. Berhnquet, L., Begin, N., Babineau, L. M., and 
Machlin, L. J., Gordon, R. S., and Puchal, F. 
Alleviation of 1-amino-cyclopentane-1-carboxylic 
acid toxicity by valine. Nature (London), 198: 
87, 1963. 
Mickelson, M. N. Effect of l-aminocyclopen- 
tanecarboxylic acid on amino acid utilization in 
various bacterial test systems. Biochem. Phar- 
macol. 5:165, 1960. 
Ross, R. B., Noll, C. I., Ross, W. C. J., Nadkami, 
M. U., Morrison, B. H., Jr., and Bond, H. W. 
Cycloaliphatic amino acids in cancer chemo- 
therapy. J. Med. Chem. 3:1, 1961. 
Sherman, F. C., Paredes, M. A., Chambers, D. 
A., and Nardi, G. L. Species differences and 
pancreatic localization of l-aminocyclopentane- 
C14-carboxylic acid. Card. 3. Biochem. 43~1243, 
1965. 
192 
